← Back to Trial

Post Marketing Study on Pluvicto in Korea

Trial Locations

• Novartis Investigative Site Seongnam-si, Gyeonggi-do, South Korea
  • Contact: Novartis Pharmaceuticals · +41613241111 · [email protected] (opens in new tab)
• Novartis Investigative Site Suwon, Gyeonggi-do, South Korea
  • Contact: Novartis Pharmaceuticals · +41613241111 · [email protected] (opens in new tab)
• Novartis Investigative Site Busan, Korea, South Korea
  • Contact: Novartis Pharmaceuticals · +41613241111 · [email protected] (opens in new tab)
• Novartis Investigative Site Gyeonggi-do, Korea, South Korea
  • Contact: Novartis Pharmaceuticals · +41613241111 · [email protected] (opens in new tab)
• Novartis Investigative Site Seoul, Seoul, South Korea
  • Contact: Novartis Pharmaceuticals · +41613241111 · [email protected] (opens in new tab)
• Novartis Investigative Site Seoul, Seoul, South Korea
  • Contact: Novartis Pharmaceuticals · +41613241111 · [email protected] (opens in new tab)
• Novartis Investigative Site Jeollanam, South Korea
  • Contact: Novartis Pharmaceuticals · +41613241111 · [email protected] (opens in new tab)
• Novartis Investigative Site Seoul, South Korea
  • Contact: Novartis Pharmaceuticals · +41613241111 · [email protected] (opens in new tab)
• Novartis Investigative Site Seoul, South Korea
  • Contact: Novartis Pharmaceuticals · +41613241111 · [email protected] (opens in new tab)
• Novartis Investigative Site Seoul, South Korea
  • Contact: Novartis Pharmaceuticals · +41613241111 · [email protected] (opens in new tab)
• Novartis Investigative Site Seoul, South Korea
  • Contact: Novartis Pharmaceuticals · +41613241111 · [email protected] (opens in new tab)
• Novartis Investigative Site Seoul, South Korea
  • Contact: Novartis Pharmaceuticals · +41613241111 · [email protected] (opens in new tab)